The Peptide Market Could Be Worth $80 Billion — Who Wins?

Wall Street is paying attention to peptides — and the numbers are getting enormous. New consumer research from Citigroup estimates the potential U.S. peptide market could eventually reach $80 BILLION a year. But there’s a catch: price appears to matter — a lot. At the same time, Eli Lilly is pursuing sellers, the FDA is tightening scrutiny on parts of the peptide supply chain, and major healthcare and telehealth companies are watching the regulatory landscape closely. So what happens when potentially massive consumer demand collides with a rapidly changing regulatory environment? In this video, I break down: • Where the $80 billion estimate comes from • Why the $90–$150 price range could dramatically affect demand • What the peptide crackdown has to do with this potential market • Why major healthcare companies are paying attention • How FDA decisions could shape which peptides consumers can legally access • And the bigger question: what will the future legitimate peptide market actually look like? The peptide story may be changing. The question may no longer be whether consumer interest exists — but how that demand ultimately fits into a legal, regulated market. 👉 Want to understand how the peptide industry actually works from manufacturing to retail? Watch my peptide supply-chain investigation next. 🔬 VERIFIED RESEARCH SOCIETY Want to learn more about peptide research, independent testing, COAs and how this industry actually works? Check out Verified Research Society. Link below. https://www.skool.com/verified-resear... ⚠️ EDUCATIONAL DISCLAIMER This content is for educational and informational purposes only and is not medical advice. PEPtalks with Mike and Verified Research Society do not sell peptides. Always consult a qualified healthcare professional regarding medical decisions. #Peptides #PeptideResearch #Retatrutide #FDA #GLP1 #Telehealth #PeptideNews